-transparent.png){kind=logo}
Thirteen patients with gynecologic cancer were treated with ifosfamide (2 g X 5), cisplatin (70 mg/m2) and adriamycin (20 mg/m2) combination chemotherapy. The response rate of 7 evaluable patients was 43%, with a median duration of survival of 14 months. Six patients with non-measurable disease are currently free from disease with a median duration of survival of 18 months. This combination caused reversible myelosuppression. No hemorrhagic cystitis was observed.
Related Publications
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
March 1989,
Journal of the National Cancer Institute,
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
July 2000,
Zhonghua zhong liu za zhi [Chinese journal of oncology],
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
December 1988,
Nihon Sanka Fujinka Gakkai zasshi,
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
May 1989,
Nihon Sanka Fujinka Gakkai zasshi,
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
September 1992,
Medicina clinica,
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
June 2006,
Clinical oncology (Royal College of Radiologists (Great Britain)),
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
February 1990,
Nihon Sanka Fujinka Gakkai zasshi,
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
August 1997,
The Journal of urology,
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
November 1987,
Gan to kagaku ryoho. Cancer & chemotherapy,
M Sawada, and
M Inagaki, and
Y Hirota, and
J Hongo, and
M Ozaki
June 1989,
Gan to kagaku ryoho. Cancer & chemotherapy,
